The impact of using the levonorgestrel-releasing intrauterine device on the incidence of acne in adolescents and young women

• Published in: European Journal of Contraception & Reproductive Health Care 2024-10, Vol.29 (5), p.1-238
• Main Authors: Oliveira, Elaine Cristina Fontes de, Senra, Janaína Campos, Rocha, Ana Luiza Lunardi
• Format: Article
• Language: English
• Subjects: Acne; Clinical trials; Cross-sectional studies; Intrauterine devices; IUD; Teenagers
• ISSN: 1362-5187; 1473-0782; 1473-0782
• DOI: 10.1080/13625187.2024.2379363

To evaluate the impact of levonorgestrel-releasing intrauterine device (LNG-IUD) use on the incidence of acne in adolescents and young women. A narrative review was conducted in PubMed, Embase, Cochrane, and SciELO assessing the incidence of acne in adolescents and young women using LNG-IUD (13.5, or 19.5 mg, or 52 mg). Cohort, cross-sectional studies, clinical trials, and meta-analyses were included, without a date limit. Studies that didn't evaluate women in the age of interest were excluded. Only articles in English were selected. Nine articles were included in this narrative review. Only clinical trials, cohort studies, and cross-sectional studies were evaluated. Two cross-sectional studies evaluated the incidence of acne in women using any contraceptive methods, with the incidence of acne being 36% in women aged 17 to 47 using LNG-IUD in one study. In another study, acne incidence ranged from 2 to 8% in women using any contraceptive methods, with higher rates in younger women and LNG-IUD users. The incidence of acne varies and participants between 16 to 35 years were more likely to report new acne or worsening of pre-existing acne. In a prospective cohort study of women between 16 and 24 years, acne was a common adverse effect, with 44% in the first year. The data indicate variability in the incidence of acne among LNG-IUD users, with a higher prevalence observed in younger women. Further research should focus on the effects of LNG-IUD on acne in young populations, with rigorous study designs and consideration of previous contraceptive use.